Chaveli-López B, Bagán-Sebastián JV. Treatment of oral mucositis due to chemotherapy. J Clin Exp Dent. 2016;8(2):e201-9.
doi:10.4317/jced.52917
References
|
1.
Chaveli López B, Gavaldá
Esteve C, Sarrión Pérez MG. Dental treatment considerations in the chemotherapy
patient. J Clin Exp Dent. 2011;3:e31-42. |
|
|
|
|
|
2. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis. 2006;12:229-41. |
|
|
|
|
|
3. Chan CW, Chang AM, Molassiotis A, Lee IY, Lee
GC. Oral complications in Chinese cancer patients undergoing chemotherapy. Support Care Cancer. 2003;11:48-55. |
|
|
|
|
|
4. Chaveli-López
B. Oral toxicity produced by chemotherapy: A systematic review. J Clin Exp Dent. 2014;6:e81-90. |
|
|
|
|
|
5. Lalla
RV, Bowen J, Barasch A, Elting
L, Epstein J, Keefe DM, et al. MASCC/ISOO clinical practice guidelines for
the management of mucositis secondary to cancer
therapy. Cancer. 2014;120:1453-61. |
|
|
|
|
|
6. Harris DJ, Eilers J, Harriman A, Cashavelly
BJ, Maxwell C. Putting evidence into practice: evidence-based interventions
for the management of oral mucositis. Clin J Oncol Nurs. 2008;12:141-52. |
|
|
|
|
|
7. Rubenstein EB, Peterson
DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice
guidelines for the prevention and treatment of cancer therapy-induced oral
and gastrointestinal mucositis. Cancer. 2004;100:2026-46. |
|
|
|
|
|
8. Nashwan
AJ. Use of chlorhexidine mouthwash in children
receiving chemotherapy: a review of literature. J Pediatr Oncol Nurs. 2011;28:295-9. |
|
|
|
|
|
9. Potting CM, Uitterhoeve R, Op Reimer WS, Van Achterberg
T. The effectiveness of commonly used mouthwashes for the prevention of
chemotherapy-induced oral mucositis: a systematic
review. Eur J Cancer Care (Engl).
2006;15:431-9. |
|
|
|
|
|
10. Worthington H V,
Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane
Database Syst Rev. 2011;4:CD000978. PMid:21491378 |
|
|
|
|
|
11. Lalla
RV, Gordon GB, Schubert M, Silverman S Jr, Hutten
M, Sonis ST. A randomized, double-blind,
placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Support Care Cancer. 2012;20:1797-804. |
|
|
|
|
|
12.
Dueńas-Gonzalez A, Sobrevilla-Calvo
P, Frias-Mendivil M, Gallardo-Rincon
D, Lara-Medina F, Aguilar-Ponce L, et al. Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis:
a randomized double-blind study. Bone Marrow Transplant. 1996;17:809-12. PMid:8733702 |
|
|
|
|
|
13.
El-Housseiny AA, Saleh
SM, El-Masry AA, Allam
AA. The effectiveness of vitamin "E" in the treatment
of oral mucositis in children receiving
chemotherapy. J Clin Pediatr
Dent. 2007;31:167-70. |
|
|
|
|
|
14. Sung L, Tomlinson GA,
Greenberg ML, Koren G, Judd P, Ota S, et al. Serial
controlled N-of-1 trials of topical vitamin E as prophylaxis for
chemotherapy-induced oral mucositis in paediatric patients. Eur J
Cancer. 2007;43:1269-75. |
|
|
|
|
|
15.
Pytlík R, Benes P, Patorková
M, Chocenská E, Gregora
E, Procházka B, et al. Standardized parenteral alanyl-glutamine
dipeptide supplementation is not beneficial in autologous transplantpatients:
a randomized, double-blind, placebo controlled study. Bone Marrow Transplant.
2002;30:953-61. |
|
|
|
|
|
16.
Peterson DE, Jones JB, Petit RG 2nd. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer. 2007;109:322-31. |
|
|
|
|
|
17. Nomura M, Kamata M, Kojima H, Hayashi K, Sawada S. Irsogladine maleate reduces the
incidence of fluorouracil-based chemotherapy-induced oral mucositis.
Ann
Oncol. 2013;24:1062-6. |
|
|
|
|
|
18. Crawford J, Tomita DK,
Mazanet R, Glaspy J, Ozer H. Reduction of oral mucositis
by filgrastim (r-metHuG-CSF)
in patients receiving chemotherapy. Cytokines Cell Mol Ther. 1999;5:187-93. |
|
|
|
|
|
19. Katano M, Nakamura M,
Matsuo T, Iyama A, Hisatsugu
T. Effect of granulocyte colony-stimulating factor (G-CSF) on
chemotherapy-induced oral mucositis. Surg Today. 1995;25:202-6. |
|
|
|
|
|
20. Karthaus
M, Rosenthal C, Huebner G, Paul H, Elser C, Hertenstein B, et al. Effect of topical oral G-CSF on
oral mucositis: a randomised
placebo-controlled trial. Bone Marrow Transplant. 1998;22:781-5. |
|
|
|
|
|
21. Ibrahim EM, al-Mulhim FA. Effect of granulocyte-macrophage
colony-stimulating factor on chemotherapy-induced oral mucositis
in non-neutropenic cancer patients. Med Oncol. 1997;14:47-51. |
|
|
|
|
|
22. Hejna
M, Köstler WJ, Raderer M,
Steger GG, Brodowicz T, Scheithauer
W, et al. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial. Eur J Cancer.
2001;37:1994-2002. PMid:11597376 |
|
|
|
|
|
23. Chi KH, Chen CH, Chan
WK, Chow KC, Chen SY, Yen SH, et al. Effect of granulocyte-macrophage
colony-stimulating factor on oral mucositis in head
and neck cancer patients after cisplatin,
fluorouracil, and leucovorin chemotherapy. J Clin Oncol. 1995;13:2620–8. |
|
|
|
|
|
24. Patte
C, Laplanche A, Bertozzi
AI, Baruchel A, Frappaz
D, Schmitt C, et al. Granulocyte colony-stimulating factor in induction
treatment of children with non-Hodgkin's lymphoma: a randomized study of the
French Society of Pediatric Oncology. J Clin Oncol. 2002;20:441-8. |
|
|
|
|
|
25. Cartee
L, Petros WP, Rosner GL,
Gilbert C, Moore S, Affronti ML, et al. Evaluation
of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging
study. Cytokine. 1995;7:471-7. |
|
|
|
|
|
26. Vadhan-Raj
S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D,
et al. Single-dose palifermin prevents severe oral mucositis during multicycle
chemotherapy in patients with cancer: A randomized trial. Ann Intern Med.
2010;153:358–67. |
|
|
|
|
|
27. Horsley P, Bauer JD, Mazkowiack R, Gardner R, Bashford
J. Palifermin improves severe mucositis,
swallowing problems, nutrition impact symptoms, and length of stay in
patients undergoing hematopoietic stem cell transplantation. Support Care
Cancer. 2007;15:105-9. |
|
|
|
|
|
28. Ayago
Flores D, Ferriols Lisart
R. Effectiveness of palifermin in the prevention of
oral mucositis in patients with haematological
cancers. Farm Hosp. 2010;34:163-9. |
|
|
|
|
|
29. Schmidt E, Thoennissen NH, Rudat A, Bieker R, Schliemann C, Mesters
RM, et al. Use of palifermin for the prevention of
high-dose methotrexate-induced oral mucositis. Ann Oncol. 2008;19:1644-9. |
|
|
|
|
|
30. Meropol
NJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK, et al. Randomized phase
I trial of recombinant human keratinocyte growth
factor plus chemotherapy: potential role as mucosal protectant.
J Clin Oncol. 2003;21:1452-8. |
|
|
|
|
|
31. Nikoletti
S, Hyde S, Shaw T, Myers H, Kristjanson LJ.
Comparison of plain ice and flavoured ice for
preventing oral mucositis associated with the use of 5 fluorouracil. J Clin Nurs. 2005;14:750-3. |
|
|
|
|
|
32. Baydar
M, Dikilitas M, Sevinc A,
Aydogdu I. Prevention of oral mucositis
due to 5-fluorouracil treatment with oral cryotherapy.
J Natl Med Assoc.
2005;97:1161-4. |
|
|
|
|
|
33. Sorensen JB, Skovsgaard T, Bork E, Damstrup
L, Ingeberg S. Double-blind, placebo-controlled,
randomized study of chlorhexidine prophylaxis for
5-fluorouracil-based chemotherapy-induced oral mucositis
with nonblinded randomized comparison to oral
cooling (cryotherapy) in gastrointestinal
malignancies. Cancer. 2008;112:1600-6. |
|
|
|
|
|
34. Papadeas
E, Naxakis S, Riga M, Kalofonos
C. Prevention of 5-fluorouracil-related stomatitis
by oral cryotherapy: A randomized controlled study.
Eur J Oncol Nurs. 2007;11:60–5. |
|
|
|
|
|
35. Lilleby
K, Garcia P, Gooley T, McDonnnell
P, Taber R, Holmberg L, et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Bone Marrow Transplant. 2006;37:1031-5. |
|
|
|
|
|
36.
Vokurka S, Bystricka E, Scudlova J, Mazur E, Visokaiova M, Vasilieva E, et
al. The risk factors for oral mucositis
and the effect of cryotherapy in patients after the
BEAM and HD-l-PAM 200 mg/m(2) autologous
hematopoietic stem cell transplantation. Eur J Oncol Nurs. 2011;15:508-12. |
|
|
|
|
|
37. Karagözoğlu
S, Filiz Ulusoy M.
Chemotherapy: the effect of oral cryotherapy on the
development of mucositis. J Clin
Nurs. 2005;14:754-65. |
|
|
|
|
|
38. Clarkson JE,
Worthington H V, Furness S, McCabe M, Khalid T, Meyer S. Interventions for
treating oral mucositis for patients with cancer
receiving treatment. Cochrane Database Syst Rev.
2010;CD001973. PMid:20687070 |
|
|
|
|
|
39. Katrancı
N, Ovayolu N, Ovayolu O, Sevinc A. Evaluation of the
effect of cryotherapy in preventing oral mucositis associated with chemotherapy - a randomized
controlled trial. Eur J Oncol
Nurs. 2012;16:339-44. |
|
|
|
|
|
40.
Freitas AC, Campos L, Brandăo TB, Cristófaro M, Eduardo Fde P, Luiz AC, et al. Chemotherapy-induced
oral mucositis: effect of LED and laser
phototherapy treatment protocols. Photomed Laser Surg. 2014;32:81-7. |
|
|
|
|
|
41.
Kuhn A, Porto FA, Miraglia
P, Brunetto AL. Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in
children. J Pediatr Hematol
Oncol. 2009;31:33-7. |
|
|
|
|
|
42.
Abramoff MM, Lopes NN, Lopes LA, Dib LL, Guilherme A, Caran EM, et al. Low-level laser therapy in the prevention and
treatment of chemotherapy-induced oral mucositis in
young patients. Photomed Laser Surg. 2008;26:393-400. |
|
|
|
|
|
43. Nes
AG, Posso MB. Patients with moderate
chemotherapy-induced mucositis: pain therapy using
low intensity lasers. Int Nurs
Rev. 2005;52:68-72. |
|
|
|
|
|
44.
Cruz LB, Ribeiro AS, Rech A, Rosa LG, Castro CG Jr, Brunetto AL. Influence of low-energy laser in the prevention of
oral mucositis in children with cancer receiving
chemotherapy. Pediatr Blood Cancer. 2007;48:435-40. |
|
|
|
|
|
45.
Waśko-Grabowska A, Rzepecki
P, Oborska S, Barzał
J, Gawroński K, Młot
B, et al. Efficiency of supersaturated calcium phosphate mouth
rinse treatment in patients receiving high-dose melphalan
or BEAM prior to autologous blood stem cell transplantation:
a single-center experience. Transplant Proc. 2011;43:3111-3. 46.
Arbabi-kalati F, Arbabi-kalati
F, Deghatipour M, Moghaddam
AA. Evaluation of the efficacy of zinc sulfate in the
prevention of chemotherapy-induced mucositis: A
double-blind randomized clinical trial. Arch Iran Med. 2012;15:413-7. |
|